青少年和年轻成人癌症幸存者后续原发性肿瘤风险(青少年和年轻成人癌症幸存者研究):一项基于人群的队列研究
该研究基于英格兰和威尔士1971年至2006年确诊的15-39岁癌症幸存者队列(200,945例),随访至2012年12月31日,分析16种青少年和年轻成人癌症后特定后续原发性肿瘤的风险。研究发现乳腺癌、宫颈癌、睾丸癌和霍奇金淋巴瘤幸存者的后续原发肿瘤绝对超额风险较高,且长期幸存者中少数特定后续原发肿瘤占超额总数的很大比例,肺癌在各组中均占显著比例。
要点
- 女性霍奇金淋巴瘤幸存者后续原发肿瘤绝对超额风险最高,为55.7/10000人年(95%CI 50.4-61.1)。
- 乳腺癌、宫颈癌、睾丸癌和霍奇金淋巴瘤幸存者诊断后35年所有后续原发肿瘤累积发病率分别为11.9%、15.8%、20.2%、26.6%(女)和16.5%(男)。
- 长期幸存者中少数特定后续原发肿瘤占超额总数的比例较高,肺癌在各组中均占显著比例。
核心结论
- 在宫颈癌、乳腺癌、睾丸癌和霍奇金淋巴瘤长期幸存者中,少数特定后续原发肿瘤占超额肿瘤总数的很大比例,为临床长期随访优先事项提供证据基础。
- 每种青少年和年轻成人癌症后肺癌的突出性表明需要进一步开展工作以预防和减轻未来幸存者的肺癌负担。
研究设计与样本
- 青少年和年轻成人癌症幸存者研究是一项基于人群的队列,纳入英格兰和威尔士1971年1月1日至2006年12月31日确诊的15-39岁癌症幸存者200,945例。
- 队列通过国家统计局癌症登记和威尔士癌症登记建立,随访从5年生存期开始至死亡、移民或研究结束日期(2012年12月31日)。
- 分析聚焦16种青少年和年轻成人癌症后特定后续原发肿瘤风险:乳腺癌、宫颈癌、睾丸癌、霍奇金淋巴瘤(女性)、霍奇金淋巴瘤(男性)、黑色素瘤、中枢神经系统(颅内)肿瘤、结直肠癌、非霍奇金淋巴瘤、甲状腺癌、软组织肉瘤、卵巢癌、膀胱癌、其他女性生殖器肿瘤、白血病和头颈癌。
- 报告每种青少年和年轻成人癌症后特定类型后续原发肿瘤的绝对超额风险(AER,每10000人年)和累积发病率。
主要发现
- 随访2,631,326人年(中位随访16.8年,IQR 10.5-25.2),11,565例幸存者诊断12,321例后续原发肿瘤,最常见于乳腺癌、宫颈癌、睾丸癌和霍奇金淋巴瘤幸存者。
- 任何后续原发肿瘤的AER:乳腺癌幸存者19.5/10000人年(95%CI 17.4-21.5),宫颈癌幸存者10.2(8.0-12.4),睾丸癌幸存者18.9(16.6-21.1),女性霍奇金淋巴瘤幸存者55.7(50.4-61.1),男性霍奇金淋巴瘤幸存者29.9(26.3-33.6)。
- 诊断后35年所有后续原发肿瘤累积发病率:乳腺癌幸存者11.9%(95%CI 11.3-12.6),宫颈癌幸存者15.8%(14.8-16.7),睾丸癌幸存者20.2%(18.9-21.5),女性霍奇金淋巴瘤幸存者26.6%(24.7-28.6),男性霍奇金淋巴瘤幸存者16.5%(15.2-18.0)。
- 在宫颈癌、睾丸癌、女性霍奇金淋巴瘤、乳腺癌和男性霍奇金淋巴瘤诊断后生存至少30年的患者中,少数特定后续原发肿瘤分别占超额肿瘤总数的82%、61%、58%、45%和41%。
- 肺癌在所有研究的青少年和年轻成人癌症组中占超额肿瘤数量的显著比例。
临床怎么用
- 作者认为,少数特定后续原发肿瘤在宫颈癌、乳腺癌、睾丸癌和霍奇金淋巴瘤长期幸存者中占超额肿瘤总数很大比例,为临床长期随访优先事项提供证据基础。
- 作者指出,每种青少年和年轻成人癌症后肺癌的突出性表明需要进一步开展工作以预防和减轻未来幸存者的肺癌负担。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few studies have investigated the risks of subsequent primary neoplasms after adolescent and young adult (AYA) cancer. We investigated the risks of specific subsequent primary neoplasms after each of 16 types of AYA cancer. METHODS: The Teenage and Young Adult Cancer Survivor Study is a population-based cohort of 200 945 survivors of cancer diagnosed when aged 15-39 years in England and Wales from Jan 1, 1971, to Dec 31, 2006. The cohort was established using cancer registrations from the Office for National Statistics and the Welsh Cancer registry. Follow-up was from 5-year survival until the first occurrence of death, emigration, or study end date (Dec 31, 2012). In this analysis, we focus on the risk of specific subsequent primary neoplasms after 16 types of AYA cancer: breast; cervical; testicular; Hodgkin lymphoma (female); Hodgkin lymphoma (male); melanoma; CNS (intracranial); colorectal; non-Hodgkin lymphoma; thyroid; soft-tissue sarcoma; ovarian; bladder; other female genital; leukaemia; and head and neck cancer. We report absolute excess risks (AERs; per 10 000 person-years) and cumulative incidence of specific types of subsequent primary neoplasm after each type of AYA cancer. FINDINGS: During the 2 631 326 person-years of follow-up (median follow-up 16·8 years, IQR 10·5-25·2), 12 321 subsequent primary neoplasms were diagnosed in 11 565 survivors, most frequently among survivors of breast cancer, cervical cancer, testicular cancer, and Hodgkin lymphoma. AERs of any subsequent primary neoplasms were 19·5 per 10 000 person-years (95% CI 17·4-21·5) in survivors of breast cancer, 10·2 (8·0-12·4) in survivors of cervical cancer, 18·9 (16·6-21·1) in survivors of testicular cancer, 55·7 (50·4-61·1) in female survivors of Hodgkin lymphoma, and 29·9 (26·3-33·6) in male survivors of Hodgkin lymphoma. The cumulative incidence of all subsequent primary neoplasms 35 years after diagnosis was 11·9% (95% CI 11·3-12·6) in survivors of breast cancer, 15·8% (14·8-16·7) in survivors of cervical cancer, 20·2% (18·9-21·5) in survivors of testicular cancer, 26·6% (24·7-28·6) in female survivors of Hodgkin lymphoma, and 16·5% (15·2-18·0) in male survivors of Hodgkin lymphoma. In patients who had survived at least 30 years from diagnosis of cervical cancer, testicular cancer, Hodgkin lymphoma in women, breast cancer, and Hodgkin lymphoma in men, we identified a small number of specific subsequent primary neoplasms that account for 82%, 61%, 58%, 45%, and 41% of the total excess number of neoplasms, respectively. Lung cancer accounted for a notable proportion of the excess number of neoplasms across all AYA groups investigated. INTERPRETATION: Our finding that a small number of specific subsequent primary neoplasms account for a large percentage of the total excess number of neoplasms in long-term survivors of cervical, breast, and testicular cancer, and Hodgkin lymphoma provides an evidence base to inform priorities for clinical long-term follow-up. The prominence of lung cancer after each of these AYA cancers indicates the need for further work aimed at preventing and reducing the burden of this cancer in future survivors of AYA cancer. FUNDING: Cancer Research UK, National Institute for Health Research, Academy of Medical Sciences, and Children with Cancer UK.
引用
- Bright CJ, Reulen RC, Winter DL, et al. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study. Lancet Oncol. 2019. PMID: 30797674. doi:10.1016/S1470-2045(18)30903-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。